Representing and utilizing clinical textual data for real world studies: An OHDSI approach

Author:

Keloth Vipina K.,Banda Juan M.,Gurley Michael,Heider Paul M.,Kennedy Georgina,Liu Hongfang,Liu Feifan,Miller Timothy,Natarajan Karthik,V Patterson Olga,Peng Yifan,Raja Kalpana,Reeves Ruth M.,Rouhizadeh Masoud,Shi Jianlin,Wang Xiaoyan,Wang Yanshan,Wei Wei-Qi,Williams Andrew E.,Zhang Rui,Belenkaya Rimma,Reich Christian,Blacketer Clair,Ryan Patrick,Hripcsak George,Elhadad Noémie,Xu Hua

Publisher

Elsevier BV

Subject

Health Informatics,Computer Science Applications

Reference77 articles.

1. Real-world evidence and real-world data for evaluating drug safety and effectiveness;Corrigan-Curay;JAMA,2018

2. Trial designs using real-world data: the changing landscape of the regulatory approval process;Baumfeld Andre;Pharmacoepidemiol. Drug Saf.,2020

3. The use of real-world data in cancer drug development;Skovlund;Eur. J. Cancer,2018

4. Treatment decisions in multiple sclerosis—insights from real-world observational studies;Trojano;Nat. Rev. Neurol.,2017

5. U.S. Food and Drug Administration - Real-World Evidence [cited 2022 Jan 30]. Available from: https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence.

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3